Initiate the Management, Oversight, and Conduct of the Niaid Dmid Clinical Trial Titled "A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of Covid-19"
Contract Overview
Contract Amount: $72,440,795 ($72.4M)
Contractor: Leidos Biomedical Research Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2020-04-01
End Date: 2023-12-31
Contract Duration: 1,369 days
Daily Burn Rate: $52.9K/day
Official Description: INITIATE THE MANAGEMENT, OVERSIGHT, AND CONDUCT OF THE NIAID DMID CLINICAL TRIAL TITLED "A MULTICENTER, ADAPTIVE, RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19".
Place of Performance
Location: Maryland, 21702
State: Maryland Government Spending